Market Place
Sourcing Support
All News #Library
Biotech
AB Science Identifies Plasma Biomarker For Masitinib In ALS
24 Feb 2026 //
GLOBENEWSWIRE
AB Science Secures US Patent for Masitinib in Metastatic Melanoma
29 Jan 2026 //
GLOBENEWSWIRE
AB Science Sees 4th Positive Response In Ab8939-Venetoclax Combo
07 Jan 2026 //
GLOBENEWSWIRE
AB Science Unveils BioRxiv Paper on AB8939 for Refractory AML
15 Dec 2025 //
GLOBENEWSWIRE
AB Science: Early Masitinib Benefits in ALS Published on MedRxiv
11 Dec 2025 //
GLOBENEWSWIRE
AB Science Reports Early Ph1 Data of AB8939 + Venetoclax in AML
16 Oct 2025 //
GLOBENEWSWIRE
Ab Science Completes 2.55 Million Euros Private Placement
04 Aug 2025 //
GLOBENEWSWIRE
AB Science Wins EU Nod for Ph I/II AML Study With AB8939
30 Jul 2025 //
GLOBENEWSWIRE
AB Science Gets Approval for Ph3 Masitinib Study in ALS in Europe
24 Jul 2025 //
GLOBENEWSWIRE
AB Science gets Chinese patent for masitinib in Covid-19
19 May 2025 //
GLOBENEWSWIRE
AB Science Updates On AB8939 Microtubule Program
26 Sep 2024 //
GLOBENEWSWIRE
AB Science announces results of Phase 2 study evaluating masitinib in Covid-19
08 Jul 2024 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.